Definition of BAY 43-9006 - NCI Dictionary of Cancer Terms

Page Options

	Quick Links


	Director's Corner Updates from the Director Dictionary of Cancer Terms Cancer-related terms NCI Drug Dictionary Definitions, names, and links Funding Opportunities Research and training NCI Publications Order/download free booklets Advisory Boards and Groups Information, meetings, reports Science Serving People Learn more about NCI Español Información en español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

Quit Smoking Today

	NCI Highlights


	Report to Nation Finds Declines in Cancer Incidence, Death Rates High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E The Nation's Investment in Cancer Research FY 2009 Past Highlights

Search for

Starts with

Contains

In English En español

BAY 43-9006

A drug used to treat advanced kidney cancer and a type of liver cancer that cannot be removed by surgery. It is also being studied in the treatment of other types of cancer. BAY 43-9006 stops cells from dividing and may prevent the growth of new blood vessels needed for tumors to grow. It is a type of kinase inhibitor and a type of angiogenesis inhibitor. Also called Nexavar, sorafenib, and sorafenib tosylate.

Previous Definitions:	baseline, basophil, batimastat, batracylin, BAY 12-9566
Next Definitions:	BAY 56-3722, BAY 59-8862, BB-10901, BBBD, BBIC